There was concern during a clinical trial with another RSV vaccine that it may cause preterm births, but the vaccine that is FDA-approved in the U.S. does not carry the same risk.

Almost all children will get RSV during their first two years, but each year up to 80,000 children are hospitalized due to it. Now, a new FDA approved vaccine can protect your baby — even before ...

Those who are six months and older are eligible to get the new vaccines, according to the FDA ... which vaccine is appropriate. The CDC recommends two options to protect babies from RSV: a ...

The expanded capacity will help the drugmakers meet the demand for Beyfortus ahead of the RSV season. The therapy was in tight supply last year. The U.S. health regulator greenlit the injected ...

The FDA in May 2023 approved both vaccines for use in older adults, a decision regarded ... with contracting RSV, and found the costs varied by age group and type of vaccine.

A third U.S. manufacturer, Novavax, expects its modified vaccine version to ... circulating variants,” said FDA vaccine chief Dr. Peter Marks. The agency’s decision came a bit earlier than ...

There are certain types of clinical studies that would not support exclusivity, and Liquidia argues this includes the study that the FDA has based its decision on. "FDA exceeded its statutory ...

The U.S. Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Moderna and Pfizer for the 2024-2025 season. The updated mRNA vaccines, Comirnaty and Spikevax, were fully ...

but the FDA should engage more effectively as well. The decision prolongs — probably for a decade — the availability of much-needed treatments. It is harmful, for all the veterans and millions ...

Company planning for every eligible baby in the US to have access to BEYFORTUS New BEYFORTUS filling line approved by the U.S. Food and Drug Administration (FDA ... (RSV) infections in infants ...

The Drug Enforcement Administration has scheduled a hearing on the Biden administration’s proposal to reclassify marijuana under federal drug laws, effectively delaying the decision until after ...